Ilex Medical Ltd (TLV:ILX)

Ilex Medical Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	165.88	177.25	148.38	200.96	259.23	159.83
Short-Term Investments	26.16	25.87	41.25	2.74	-	-
Trading Asset Securities	30.47	33.76	27.48	22	25.52	15.93
Cash & Short-Term Investments	222.51	236.88	217.11	225.7	284.75	175.75
Cash Growth	-7.33%	9.11%	-3.81%	-20.74%	62.02%	101.31%
Accounts Receivable	260.04	249.37	286.25	248.26	219.99	239.46
Other Receivables	17.71	17.56	15.57	3.04	3.73	0.38
Receivables	277.75	266.93	301.82	251.3	223.72	239.84
Inventory	155.44	157.89	159.68	145.8	116.32	136.68
Other Current Assets	41.18	56.77	7.39	12.02	6.93	6.72
Total Current Assets	696.87	718.47	686.01	634.83	631.72	558.99
Property, Plant & Equipment	152.63	155.46	160.91	145.28	151.41	154.78
Long-Term Investments	73.55	53.71	57.95	72.66	32.1	0.45
Goodwill	7.01	7.01	7.01	7.01	-	-
Other Intangible Assets	15.32	17.08	21.27	25.06	25.87	31.69
Long-Term Accounts Receivable	-	34.91	28.51	5.73	3.75	6.42
Long-Term Deferred Tax Assets	7.25	7.42	8.51	6.35	6.35	4.46
Long-Term Deferred Charges	-	-	-	0.04	0.08	0.08
Other Long-Term Assets	34.46	0.01	45.95	2.23	23.8	22.38
Total Assets	987.09	994.07	1,016	899.18	875.07	779.25
Accounts Payable	121.99	120.44	172.11	142.32	124.39	162.79
Accrued Expenses	-	-	-	-	-	40.2
Short-Term Debt	-	-	-	-	-	0.22
Current Portion of Long-Term Debt	0.21	0.31	0.41	0.56	1.13	15.27
Current Portion of Leases	12.75	12.22	11.47	12.28	11.96	8.56
Current Income Taxes Payable	4.78	4.5	1.4	2.22	40.39	7.22
Current Unearned Revenue	-	-	-	-	-	33.4
Other Current Liabilities	128.53	130.4	93.15	68.45	62.23	11.58
Total Current Liabilities	268.25	267.87	278.54	225.83	240.11	279.22
Long-Term Debt	-	-	0.31	0.73	1.29	2.42
Long-Term Leases	36.38	38.81	36.07	37.99	44.36	40.28
Long-Term Unearned Revenue	21.25	25.28	60.33	4.11	-	6.08
Long-Term Deferred Tax Liabilities	1.88	2.55	2.94	3.15	6.72	7.58
Other Long-Term Liabilities	11.97	12.12	12.77	14.28	7.02	0.12
Total Liabilities	340.68	347.58	392.61	286.08	299.49	335.71
Common Stock	12.48	12.48	12.48	12.48	12.48	12.48
Additional Paid-In Capital	150.5	150.5	150.5	150.5	150.5	150.5
Retained Earnings	564.04	568.58	544.92	515.41	472.39	334.63
Treasury Stock	-9.2	-9.2	-9.2	-3.49	-	-
Comprehensive Income & Other	-71.41	-75.86	-75.19	-61.79	-59.79	-54.07
Total Common Equity	646.41	646.49	623.51	613.1	575.57	443.54
Shareholders' Equity	646.41	646.49	623.51	613.1	575.57	443.54
Total Liabilities & Equity	987.09	994.07	1,016	899.18	875.07	779.25
Total Debt	49.33	51.35	48.27	51.55	58.74	66.74
Net Cash (Debt)	173.18	185.53	168.84	174.15	226.02	109.01
Net Cash Growth	-8.89%	9.88%	-3.04%	-22.95%	107.33%	-
Net Cash Per Share	15.44	16.58	15.09	15.44	20.04	10.22
Filing Date Shares Outstanding	11.25	11.19	11.28	11.28	11.28	11.28
Total Common Shares Outstanding	11.25	11.19	11.19	11.25	11.28	11.28
Working Capital	428.62	450.6	407.47	409	391.61	279.77
Book Value Per Share	57.47	57.78	55.73	54.52	51.02	39.32
Tangible Book Value	624.09	622.4	595.24	581.04	549.7	411.85
Tangible Book Value Per Share	55.48	55.63	53.20	51.67	48.73	36.51
Land	-	0.06	0.06	0.06	0.06	0.06
Machinery	-	254.19	244.49	212.94	193.36	188.2
Leasehold Improvements	-	17.78	25.19	24.04	25.51	25.36

Updated Nov 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.